AI assistant
Cencora, Inc. — Director's Dealing 2016
Mar 22, 2016
29973_dirs_2016-03-22_551af106-61b7-4998-ad5f-9efcadb1dde7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMERISOURCEBERGEN CORP (ABC)
CIK: 0001140859
Period of Report: 2016-03-18
Reporting Person: Walgreens Boots Alliance, Inc. (10% Owner)
Reporting Person: Walgreens Boots Alliance Holdings LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-18 | Common Stock | X | 22696912 | $51.50 | Acquired | 34157955 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-03-18 | Warrants (right to buy) | $51.50 | X | 22696912 | Disposed | 2016-09-18 | Common Stock (22696912) | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants (right to buy) | $52.50 | 2017-09-18 | Common Stock (22696912) | 22696912 | Indirect |
Footnotes
F1: These shares are held by Walgreens Boots Alliance Holdings LLC ("WBA Holdings"), an indirect wholly-owned subsidiary of Walgreens Boots Alliance, Inc. ("WBA"), and were acquired in accordance with the Framework Agreement, dated as of March 18, 2013 among Walgreen Co. ("Walgreen"), Alliance Boots GmbH and the Issuer (the "Framework Agreement"). The Framework Agreement is described in a Schedule 13D filed by Walgreen and others on April 15, 2014, as amended on January 16, 2015, January 25, 2016 and March 22, 2016 (as amended, the "Schedule 13D").
F2: These warrants are held by WBA Holdings and were acquired pursuant to the Framework Agreement.
F3: As described in the Schedule 13D, following the completion of an internal reorganization of certain wholly-owned subsidiaries of WBA, WBA Investments, Inc., a direct wholly-owned subsidiary of WBA and the sole member of WBA Holdings, may also be deemed to beneficially own the securities reported in this Form 4 and each of Walgreens Pharmacy Strategies, LLC, Bond Drug Company of Illinois, LLC, Walgreen Eastern Co., Inc., Walgreen Arizona Drug Co., Walgreen Hastings Co. and Walgreen do not beneficially own any shares of common stock or warrants of the Issuer.